Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium hyaluronate is the sodium salt of hyaluronic acid—a naturally occurring glycosaminoglycan found in connective tissues. It acts as a lubricant and shock absorber in joints and is used primarily to relieve pain from osteoarthritis of the knee when other treatments have failed. Sodium hyaluronate is also used as a surgical aid in ophthalmic procedures to protect eye tissues and as a topical agent for wound healing. Its mechanism of action involves forming a viscoelastic solution that provides mechanical protection for tissues by absorbing stress and serving as a protective buffer. It may also facilitate tissue repair by transporting growth factors to sites of injury[1][2][3][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium hyaluronate.